modelling, will facilitate this process and provide important
information for the control of drug-resistant TB.
The growing threat of MDR- and XDR-TB highlights the need for
a better understanding of the complexity of drug resistance in
M.tb. This will allow the development of enhanced diagnostic tests
to identify resistant strains and strategies to curb their spread, and
also help the design of more powerful anti-TB drugs.
Conflict of interest: None to declare